Twin Tree Management, LP Vertex Pharmaceuticals Inc Put Options Transaction History

Twin Tree Management, LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 09, 2024	BUY	$407.69 - $446.08 $49.8 Million - $54.5 Million	122,200 New	122,200 $51.1 Million
Q1 2022 May 11, 2022	SELL	$221.42 - $260.97 $4.45 Million - $5.25 Million	-20,100 Reduced 28.92%	49,400 $12.9 Million
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $11.5 Million - $14.6 Million	65,200 Added 1516.28%	69,500 $15.3 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $133,368 - $179,128	800 Added 22.86%	4,300 $941,000
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $573,055 - $681,450	3,500 New	3,500 $644,000
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $2.89 Million - $3.65 Million	-19,000 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$167.73 - $192.74 $13.9 Million - $15.9 Million	-82,600 Reduced 81.3%	19,000 $3.66 Million
Q4 2017 Feb 09, 2018	SELL	$137.28 - $155.55 $7.69 Million - $8.71 Million	-56,000 Reduced 35.53%	101,600 $15.2 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $23.3 Million - $25.6 Million	157,600	157,600 $24 Million

1,717

226M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.